Minnie Baylor-Henry is president of Baylor-Henry Associates. She is the former worldwide vice president for regulatory affairs, Johnson & Johnson (J&J) Medical Devices & Diagnostics. In this capacity, she was responsible for coordinating the regulatory strategy for J&J’s device companies.
Her other experience includes being vice president for global regulatory affairs OTC at McNeil Consumer Healthcare, a J&J company; and senior director of Pharmaceutical Research & Development. Previously, Ms. Baylor-Henry served as a consultant in the Life Sciences Regulatory Practice at Deloitte & Touche LLP and a former director of the Drug Marketing, Advertising, and Communications division of the U.S. Food and Drug Administration (FDA). She also served as national health fraud coordinator in the FDA’s Office of Regulatory Affairs. She is the past president of the Drug Information Association and former president of the Food and Drug Law Institute.
Ms. Baylor-Henry received her pharmacy degree from Howard University’s College of Pharmacy and a law degree from Catholic University’s Columbus School of Law. A registered pharmacist (R.Ph.), she is a member of the Board of Visitors of the College of Pharmacy.